George L. O'Brien is the CEO of Charles River Laboratories, a company known for helping with drug development and testing. He joined Charles River in 2005 and has been a significant figure in its growth. George's leadership has been marked...
George L. O'Brien is the CEO of Charles River Laboratories, a company known for helping with drug development and testing. He joined Charles River in 2005 and has been a significant figure in its growth. George's leadership has been marked by his focus on performance metrics, which include earnings per share and revenue growth, aligning executive pay with company success. In 2016, he earned just over $13 million, a mix of salary, bonuses, and other compensation, but no stock grants that year showed how much he relies on performance-based pay. His history in trading showcases confidence in the company's direction, with notable insider trading amounts climbing sharply from around $1 million monthly in 2019 to over $4 million by 2021, highlighting his strong belief in Charles River's prospects. In a significant move in 2018, George consolidated his control further by taking on the president role as well, after the COO position was eliminated, showing his hands-on approach to management.